NCT04005651View on ClinicalTrials.gov

Safety and Efficacy of a Trifocal Intraocular Lens (IOL) POD L GF in Comparison With a Multifocal and a Monofocal IOL

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 30, 2019

Primary Completion Date

July 27, 2022

Study Completion Date

November 29, 2022

Conditions
Aphakia, PostcataractCataract; Eye Disease
Interventions
DEVICE

POD L GF IOL

Cataractous lens will be removed in the study eyes and the POD L GF IOL will be implanted in the capsular bag

DEVICE

Symfony® IOL

Cataractous lens will be removed in the study eyes and the Symfony® IOL will be implanted in the capsular bag

DEVICE

AcrySof® IOL

Cataractous lens will be removed in the study eyes and the AcrySof® IOL will be implanted in the capsular bag

Trial Locations (5)

28003

IOA Madrid Innova Ocular, Madrid

40212

Internationale Innovative Ophthalmochirgie, Düsseldorf

44300

OphtALLIANCE Clinique Jules Verne, Nantes

48429

Augentagesklinik Rheine, Rheine

48683

Augenklinik Ahaus, Ahaus

All Listed Sponsors
lead

Beaver-Visitec International, Inc.

INDUSTRY

NCT04005651 - Safety and Efficacy of a Trifocal Intraocular Lens (IOL) POD L GF in Comparison With a Multifocal and a Monofocal IOL | Biotech Hunter | Biotech Hunter